Page last updated: 2024-08-21

cyclopentane and mdl 100907

cyclopentane has been researched along with mdl 100907 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kłodzińska, A; Neuville, P; Palucha-Poniewiera, A; Pilc, A; Schann, S; Stachowicz, K1

Other Studies

1 other study(ies) available for cyclopentane and mdl 100907

ArticleYear
The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Neuropharmacology, 2009, Volume: 57, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cyclopentanes; Depression; Flumazenil; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Injections, Intraperitoneal; Male; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Stress, Psychological; Tricarboxylic Acids

2009